LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
SES
SES AI Corporation
There isn't enough reported data to score SES yet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SES Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Weak | |
| Unavailable |
SES's profitability and cash flow are currently weak. There isn't enough data to rate its revenue and balance sheet.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
SES PE Valuation
SES has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
SES Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect SES's revenue to grow, with its earnings and profitability holding steady.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over SES on earnings, with more consistent year-over-year improvement.
SES Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.18 | +$0.10 |
| Q2 2026 | -$0.20 | +$0.11 |
| Q1 2026 | -$0.22 | +$0.08 |
| Q4 2025 | -$0.22 | +$0.09 |
| Q3 2025 | -$0.28 | -$0.04 |
| Q2 2025 | -$0.31 | -$0.12 |
| Q1 2025 | -$0.30 | -$0.13 |
| Q4 2024 | -$0.31 | -$0.14 |
SES is still losing money, but less than at its worst: $0.18 per share over the past year, against $0.31 at its worst in late 2024.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over SES in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID has the edge over SES on profitability, with a higher operating margin.
SES Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $6.6M | -6.7% |
| Q2 2026 | $5.1M | +44% |
| Q1 2026 | $6.7M | +16% |
SES's revenue is growing: $7M last quarter, down 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -277% | -15 points |
| Q2 2026 | -378% | +274 points |
| Q1 2026 | -266% | +136 points |
| Q4 2025 | -388% | N/A |
| Q3 2025 | -262% | N/A |
| Q2 2025 | -652% | N/A |
| Q1 2025 | -402% | N/A |
SES's operating margin was −277% last quarter, down 15 points from the same quarter a year ago.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
SES Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$16.7M | -$2M |
| Q2 2026 | -$14.5M | -$2.9M |
| Q1 2026 | -$20.1M | +$3.6M |
| Q4 2025 | -$11.1M | +$1.4M |
| Q3 2025 | -$14.7M | +$9.5M |
| Q2 2025 | -$11.6M | +$14.2M |
| Q1 2025 | -$23.7M | -$8M |
| Q4 2024 | -$12.5M | +$3.5M |
SES has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
SES Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -1.8M shares |
| 1 year | +1% | +3.2M shares |
| 3 years | +6% | +18.9M shares |
| 5 years | +3165% | +324M shares |
SES has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q4 2019 | $263,000 |
| Q3 2019 | — |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SES Net Leverage
SES's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
SES Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.0 | Neutral |
| Stochastic | 42.1 | Neutral |
SES's weekly RSI is 41 (neutral) and its Stochastic is 42 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
SES PE vs Consumer Cyclical Sector
SES has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
SES Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.73 | 21% below |
| 20 week MA | $0.65 | 11% below |
| 50 week MA | $1.15 | 50% below |
| 100 week MA | $1.21 | 52% below |
| 200 week MA | $1.47 | 61% below |
SES is in a downtrend: it's below all five of its weekly moving averages, and 61% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
SES Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $10.0 | $9.94 | -0.6% |
| 2022 | $9.94 | $3.46 | -65% |
| 2023 | $3.46 | $1.83 | -47% |
| 2024 | $1.83 | $2.39 | +31% |
| 2025 | $2.39 | $1.97 | -18% |
| 2026 YTD | $1.97 | $0.58 | -71% |
SES has the edge over LCID on returns for 2026, with the stronger performance.